참고문헌 (37)

1. The Society of Korean Dermatology. Textbook of Dermatology. 6th ed. Seoul; Daehan Medical book. 2015:299-314. 

2. Youn SW. Recent medical therapy for psoriasis. J Korean Med Assoc. 2019;62 (3):176-80. 

   상세보기

3. Pietrzak A, Michalak-Stoma A, Chodorowska G, Szepietowski JC. Lipid disturbances in psoriasis: An update. Mediators of Inflammation. 2010;2010:1-13. 

4. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):1-14. 

5. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: Implications for management. J Am Acad Dermatol. 2017;76(3):393-403. 

   상세보기

6. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. J Am Med Assoc. 2020;323(19):1945-60. 

   상세보기

7. Lee S. Psoriasis and Skin Barrier. J Ski Barrier Res. 2017;19(1):25-9. 

8. Han CY, Kim JD, Kang DW, Kim KS, Kim YB. Review about using Herbal medicine on steroid tapering and steroid overuse in Skin disease. J Korean Med Ophthalmol Otolaryngol Dermatol. 2020;33(3):115-24. 

   원문보기 상세보기

9. Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20 (6):1-28. 

10. Ogawa E. Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Der. 2018;45:264-72. 

11. Gisondi P, Fostini AC, Fossa I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21-8. 

    상세보기

12. Pietrzak A, Chodorowska G, Szepietowski J, Zalewska-Janowska A, Krasowska D, Hercogova J. Psoriasis and serum lipid abnormalities. Dermatol Ther. 2010;23(2): 160-73. 

    상세보기

13. Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clin Dermatol. 2014;32(3):343-50. 

    상세보기

14. Kang DW, Han CY, Kim JD, Kim KS, Kim YB. A Proposal and Considerations for Treatment Approaches of Psoriasis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2020;33(3):99-114. 

    원문보기 상세보기

15. Asad F, Khan M, Rizvi F. Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis. Pakistan J Med Sci. 2017;33(6):1507-11. 

16. Zuccotti E, Oliveri M, Girometta C, Ratto D, Di Iorio C, Occhinegro A, et al. Nutritional strategies for psoriasis: Current scientific evidence in clinical trials. Eur Rev Med Pharmacol Sci. 2018;22(23):8537-51. 

17. Upala S, Sanguankeo A. Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: A systematic review and meta-analysis. Int J Obes. 2015;39(8):1197-202. 

    상세보기

18. Sarvtin MT, Hedayati MT, Shokohi T, HajHeydari Z. Serum lipids and lipoproteins in patients with psoriasis. Arch Iran Med. 2014;17(5):343-6. 

19. Shih CM, Chen CC, Chu CK, Wang KH, Huang CY, Lee AW. The roles of lipoprotein in psoriasis. Int J Mol Sci. 2020;21(3):1-12. 

20. Sorokin AV, Domenichiello AF, Dey AK, Yuan ZX, Goyal A, Rose SM, et al. Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood. J Invest Dermatol. 2018;138(7):1518-28. 

    상세보기

21. Kim BH, Kim KI, Kang SH, Park JG, Kang DW, Nam HJ, et al. Explanation and Elaboration of the Clinical Trial Guidelines for Psoriasis Using Herbal Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol. 2018;31(2):40-59. 

    원문보기 상세보기

22. Jeung CW, Jeon SW, Jo HG. Literature Review on Herbal Medicine Treatment of Psoriasis Based on Chronic Low-grade Inflammation Theory. J Korean Med Ophthalmol Otolaryngol Dermatol. 2018;31 (4):22-30. 

    원문보기 상세보기

23. Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z, et al. 'Psoriasis 1' reduces psoriasis-like skin inflammation by inhibiting the VDRmediated nuclear NF-kB and STAT signaling pathways. Mol Med Rep. 2018;18(3): 2733-43. 

24. Yan Y, Liu W, Andres P, Pernin C, Chantalat L, Briantais P, et al. Exploratory clinical trial to evaluate the efficacy of a topical traditional Chinese herbal medicine in psoriasis vulgaris. Evid Based Complement Alternat Med. 2015;201:719641. 

25. Weng SW, Chen BC, Wang YC, Liu CK, Sun MF, Chang CM, et al. Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study. Evid Based Complement Alternat Med. 2016;2016:3164105. 

    상세보기

26. Rouhi-Boroujeni H, Rouhi-Boroujeni H, Heidarian E, Mohammadizadeh F, RafieianKopaei M. Herbs with anti-lipid effects and their interactions with statins as a chemical anti-hyperlipidemia group drugs: A systematic review. ARYA Atheroscler. 2015;11(4):244-51. 

    상세보기

27. Yokoi H, Mizukami H, Nagatsu A, Ohno T, Tanabe H, Inoue M. Peroxisome Proliferator- Activated Receptor g Ligands Isolated from Adlay Seed. Biol Pharm Bull. 2009;32(4):735-40. 

    상세보기

28. Song MY, Jung HW, Park YK. Antiobesity Effect of Water Extract of Coix lacrymajobi var. mayuen in High Fat Fed C5BL/6 Mice. J Korean Med Obes Res. 2016;16(1):27-35. 

    원문보기 상세보기

29. Kim BM, Jo HG. Progress of Short-term Herbal Medicine Administration for Hypertriglyceridemia: a Case Report. J. Int. Korean Med. 2019;40(3):517-24. 

    원문보기 상세보기

30. Kim DS, Jeon BK, Mun YJ, Lee GT, Lee KK, Woo WH. Ponciri Fructus Extract Induces Lipogenesis through Transcription Factor SREBP-1 Activation. Yakhak Hoeji. 2012; 56(4):268-73. 

31. Wu F, Yang X, Hu M, Shao Q, Fang K, Li J, et al. Wu-Mei-Wan prevents high-fat diet-induced obesity by reducing white adipose tissue and enhancing brown adipose tissue function. Phytomedicine. 2020;76:153258. 

    상세보기

32. Sin SM, Cha JH, Kim GT, Byun SH, Ko H. Saenggangeonbi-tang's effest on metabolic syndrome Department. J Intern Korean Med. 2008;fal:65-70. 

33. Lee IW, Choi HY, Lee JH, Park SD, Kim SM, Ku SK, et al. Saeng-Kankunbi-Tang protects liver against oxidative damage through activation of ERK/Nrf2 pathway. Chin J Integr Med. 2016;22(8):619-28. 

    상세보기

34. Masayuki I, Takashi S, Koh I, Kazuichi S. Chinese Herbal Medicine Yi-Gan-San Decreases the Lipid Accumulation in Mouse 3T3-L1 Adipocytes by Modulating the Activities of Transcription Factors SREBP-1c and FoxO1. Tohoku J. Exp. Med. 2009; 219:53-62. 

    상세보기

35. Lee JM, Cho SW, Kang KH, Lee SY, Yu S. The Effects of Daecheongryong-tang on transcription factors and adipogenic genes during 3T3-L1 differentiation. The Journal of Pediatrics of Korean Medicine. 2010; 24(3):92-105. 

36. Xie X, Zhang L, Li X, Liu W, Wang P, Lin Y, et al. Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway. Front Pharmacol. 2021;12:1-13. 

37. Cho JG, Yang YH, Han SR, Cho AR. 3 Cases Reports of Psoriasis Treated by Damwihwan- Focused on Lipid Metabolic Abnomarilty. J Korean Med Ophthalmol Otolaryngol Dermatol 2017;30(4):167-75. 

    원문보기 상세보기

저자의 다른 논문 :

김규석 (61) 김윤범 (132)